Chronic Disease Management Market - 2024-2031
Chronic Disease Management Market reached US$ 4.8 billion in 2022 and is expected to reach US$ 14.6 billion by 2031, growing with a CAGR of 11.40% during the forecast period 2026-2031.
The Chronic Disease Management Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Chronic Disease Management Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Type
Both primary and secondary data sources have been used in the global Chronic Disease Management Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The Chronic Disease Management Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Chronic Disease Management Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Type
- Solution*
- Services
- Consulting Services*
- Educational Service
- Implementation Service
- Others
- On-Premise Solution*
- Cloud-Based Solution
- Web-Based
- Cardiovascular Diseases (CVD)*
- Diabetes
- Chronic Obstructive Pulmonary Disorders (COPD)
- Arthritis
- Asthma
- Cancer
- Others
- Healthcare Providers*
- Healthcare Payers
- Others
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Chronic Disease Management Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Type
3.2. Snippet by Service Type
3.3. Snippet by Delivery Mode
3.4. Snippet by Indication
3.5. Snippet by Application
3.6. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Technological advancements
4.1.1.2. Active Major Players in Chronic Disease Management Solutions
4.1.1.3. Collaboration Among Major Players to Develop Advanced Solution
4.1.1.4. Digital Therapeutics Play an Important Role in Chronic-Disease Management
4.1.2. Restraints
4.1.2.1. High Costs for Designing and Implementation of Chronic Disease Management Platform
4.1.2.2. Patient Engagement Challenges
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Solution*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Services
8. BY SERVICE TYPE
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
8.1.2. Market Attractiveness Index, By Service Type
8.2. Consulting Services*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Educational Service
8.4. Implementation Service
8.5. Others
9. BY DELIVERY MODE
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
9.1.2. Market Attractiveness Index, By Delivery Mode
9.2. On-Premise Solution*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Cloud-Based Solution
9.4. Web-Based
10. BY INDICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.1.2. Market Attractiveness Index, By Indication
10.2. Cardiovascular Diseases (CVD)*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diabetes
10.4. Chronic Obstructive Pulmonary Disorders (COPD)
10.5. Arthritis
10.6. Asthma
10.7. Cancer
10.8. Others
11. BY END-USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
11.1.2. Market Attractiveness Index, By End-user
11.2. Healthcare Providers*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Healthcare Payers
11.4. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. UK
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
14.1. Allscripts Healthcare Solutions Inc.*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. TriZetto Corporation
14.3. Siemens Healthcare Private Limited
14.4. IBM
14.5. Pegasystems Inc.
14.6. Koninklijke Philips NV
14.7. EXL Healthcare
14.8. Infosys Limited
14.9. ScienceSoft USA Corporation
14.10. ZeOmega (*LIST NOT EXHAUSTIVE)
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Type
3.2. Snippet by Service Type
3.3. Snippet by Delivery Mode
3.4. Snippet by Indication
3.5. Snippet by Application
3.6. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Technological advancements
4.1.1.2. Active Major Players in Chronic Disease Management Solutions
4.1.1.3. Collaboration Among Major Players to Develop Advanced Solution
4.1.1.4. Digital Therapeutics Play an Important Role in Chronic-Disease Management
4.1.2. Restraints
4.1.2.1. High Costs for Designing and Implementation of Chronic Disease Management Platform
4.1.2.2. Patient Engagement Challenges
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Solution*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Services
8. BY SERVICE TYPE
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
8.1.2. Market Attractiveness Index, By Service Type
8.2. Consulting Services*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Educational Service
8.4. Implementation Service
8.5. Others
9. BY DELIVERY MODE
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
9.1.2. Market Attractiveness Index, By Delivery Mode
9.2. On-Premise Solution*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Cloud-Based Solution
9.4. Web-Based
10. BY INDICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.1.2. Market Attractiveness Index, By Indication
10.2. Cardiovascular Diseases (CVD)*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diabetes
10.4. Chronic Obstructive Pulmonary Disorders (COPD)
10.5. Arthritis
10.6. Asthma
10.7. Cancer
10.8. Others
11. BY END-USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
11.1.2. Market Attractiveness Index, By End-user
11.2. Healthcare Providers*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Healthcare Payers
11.4. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. UK
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
14.1. Allscripts Healthcare Solutions Inc.*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. TriZetto Corporation
14.3. Siemens Healthcare Private Limited
14.4. IBM
14.5. Pegasystems Inc.
14.6. Koninklijke Philips NV
14.7. EXL Healthcare
14.8. Infosys Limited
14.9. ScienceSoft USA Corporation
14.10. ZeOmega (*LIST NOT EXHAUSTIVE)
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
